NEW YORK (Reuters Health) – In a phase III, multinational study of patients with heavily pretreated metastatic breast cancer, adding sunitinib to capecitabine provided no benefit, and in…
NEW YORK (Reuters Health) – The results of a phase III Italian study indicate that the risk of breast cancer in postmenopausal women who use hormone replacement therapy…
By Andrew M. Seaman NEW YORK (Reuters Health) – Low-dose aspirin, even if not taken daily, may reduce a woman’s risk of colon cancer over the long term,…
NEW YORK (Reuters Health) – Physicians caring for women who are at increased risk for breast cancer should discuss with them the risks and benefits of specific chemoprevention…
NEW YORK (Reuters Health) – The cumulative incidence of osteonecrosis of the jaw was about 2% over 6 years among women with early breast cancer who received intensive…
By David Douglas NEW YORK (Reuters Health) – Dual HER2 blockade didn’t increase heart problems in a meta-analysis of data from patients with HER2-positive breast cancer. “The combination…
Herbert Insel, MD, and Clinical Instructor at NYU Langone Medical Center, discusses the benefits of a prudent lifestyle. He councils fellow physicians on how to educate patients on a prudent lifestyle,…
The Doctor’s Channel’s very own David Best, MD, MBA, and MedGadget‘s Shiv Gaglani, MD-MBA candidate, team up to bring you the hottest new gadgets for physicians and patients.…
Some pregnant women express concerns over the possibility of pain, vaginal tearing and other risks for themselves and their children. A cesarean delivery on maternal request (CDMR) may not always…
Herbert Insel, MD, and Clinical Instructor at NYU Langone Medical Center, talks about the latest research on the health benefits of the Mediterranean Diet. He explains the the diet…